Oncogene - Table of Contents alert Volume 32 Issue 5

TABLE OF CONTENTS Volume 32, Issue 5 (January 2013) In this issue Review Original Articles Short Communication Corrigendum Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Review Top The Greatwall kinase: a new pathway in the control of the cell cycle T Lorca and A Castro Oncogene 2013 32: 537-543; advance online publication, April 2, 2012; 10.1038/onc.2012.79 Abstract | Full Text Original Articles Top CD133+ cells with cancer stem cell characteristics associates with vasculogenic mimicry in triple-negative breast cancer T J Liu, B C Sun, X L Zhao, X M Zhao, T Sun, Q Gu, Z Yao, X Y Dong, N Zhao and N Liu Oncogene 2013 32: 544-553; advance online publication, April 2, 2012; 10.1038/onc.2012.85 Abstract | Full Text FOXA1 represses the molecular phenotype of basal breast cancer cells G M Bernardo, G Bebek, C L Ginther, S T Sizemore, K L Lozada, J D Miedler, L A Anderson, A K Godwin, F W Abdul-Karim, D J Slamon and R A Keri Oncogene 2013 32: 554-563; advance online publication, March 5, 2012; 10.1038/onc.2012.62 Abstract | Full Text Oncogenic KRAS and BRAF activation of the MEK/ERK signaling pathway promotes expression of dual-specificity phosphatase 4 (DUSP4/MKP2) resulting in nuclear ERK1/2 inhibition S Cagnol and N Rivard Oncogene 2013 32: 564-576; advance online publication, March 19, 2012; 10.1038/onc.2012.88 Abstract | Full Text Synthetic lethality of Chk1 inhibition combined with p53 and/or p21 loss during a DNA damage response in normal and tumor cells S Origanti, S-r Cai, A Z Munir, L S White and H Piwnica-Worms Oncogene 2013 32: 577-588; advance online publication, March 19, 2012; 10.1038/onc.2012.84 Abstract | Full Text SIRT1 deacetylase promotes acquisition of genetic mutations for drug resistance in CML cells Z Wang, H Yuan, M Roth, J M Stark, R Bhatia and W Y Chen Oncogene 2013 32: 589-598; advance online publication, March 12, 2012; 10.1038/onc.2012.83 Abstract | Full Text Histone deacetylase inhibitors suppress mutant p53 transcription via histone deacetylase 8 W Yan, S Liu, E Xu, J Zhang, Y Zhang, X Chen and X Chen Oncogene 2013 32: 599-609; advance online publication, March 5, 2012; 10.1038/onc.2012.81 Abstract | Full Text The WRN and MUS81 proteins limit cell death and genome instability following oncogene activation I Murfuni, S Nicolai, S Baldari, M Crescenzi, M Bignami, A Franchitto and P Pichierri Oncogene 2013 32: 610-620; advance online publication, March 12, 2012; 10.1038/onc.2012.80 Abstract | Full Text Minor cell-death defects but reduced tumor latency in mice lacking the BH3-only proteins Bad and Bmf F Baumgartner, C Woess, V Pedit, A Tzankov, V Labi and A Villunger Oncogene 2013 32: 621-630; advance online publication, March 19, 2012; 10.1038/onc.2012.78 Abstract | Full Text The role of TRKA signaling in IL-10 production by apoptotic tumor cell-activated macrophages S Ley, A Weigert, B Weichand, N Henke, B Mille-Baker, R A J Janssen and B Brüne Oncogene 2013 32: 631-640; advance online publication, March 12, 2012; 10.1038/onc.2012.77 Abstract | Full Text EpCAM regulates cell cycle progression via control of cyclin D1 expression A Chaves-Pérez, B Mack, D Maetzel, H Kremling, C Eggert, U Harréus and O Gires Oncogene 2013 32: 641-650; advance online publication, March 5, 2012; 10.1038/onc.2012.75 Abstract | Full Text Alveolar rhabdomyosarcoma-associated proteins PAX3/FOXO1A and PAX7/FOXO1A suppress the transcriptional activity of MyoD-target genes in muscle stem cells F Calhabeu, S Hayashi, J E Morgan, F Relaix and P S Zammit Oncogene 2013 32: 651-662; advance online publication, June 18, 2012; 10.1038/onc.2012.73 Abstract | Full Text Short Communication Top Tumor development is associated with decrease of TET gene expression and 5-methylcytosine hydroxylation H Yang, Y Liu, F Bai, J-Y Zhang, S-H Ma, J Liu, Z-D Xu, H-G Zhu, Z-Q Ling, D Ye, K-L Guan and Y Xiong Oncogene 2013 32: 663-669; advance online publication, March 5, 2012; 10.1038/onc.2012.67 Abstract | Full Text Corrigendum Top Connective tissue growth factor modulates oral squamous cell carcinoma invasion by activating a miR-504/FOXP1 signalling M-H Yang, B-R Lin, C-H Chang, S-T Chen, S-K Lin, M Y-P Kuo, Y-M Jeng, M-L Kuo and C-C Chang Oncogene 2013 32: 670; 10.1038/onc.2012.559 Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2013 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.